HighVista Strategies’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

HighVista Strategies’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,557	Closed	-$1M	–	170
2023 Q2	$1M	Sell	21,557 -45,800	-68%	-$1.58M	0.46%	47
2023 Q1	$1.93M	Buy	67,357 +28,293	+72%	+$838K	1.57%	25
2022 Q4	$1.22M	Buy	+39,064	New	+$1.27M	0.72%	36
2022 Q2	–	Sell	-48,960	Closed	-$937K	–	122
2022 Q1	$937K	Buy	+48,960	New	+$874K	0.6%	40

HighVista Strategies's DICE Position: Q3 2023 in Review

HighVista Strategies sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 21,557 shares — an estimated $1M sold.

HighVista Strategies first reported a position in DICE in Q1 2022 and held it in 4 quarters. The position peaked at $1.93M in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

HighVista Strategies reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HighVista Strategies sold 21,557 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1M.
HighVista Strategies first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
HighVista Strategies's DICE Therapeutics, Inc. Common Stock position peaked at $1.93M in Q1 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on HighVista Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.